Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-24 @ 6:38 PM
NCT ID:
NCT07222657
Eligibility Criteria:
Inclusion Criteria:
* Adults with locally advanced EAC who are expected to receive FLOT +/-Durvalumab will be eligible to participate.
* Locally advanced esophageal cancer is defined as TNM stages T1N+M0 or T2-T4aNanyM0, as defined by endoscopic ultrasound (EUS) and PET-CT.
Exclusion Criteria:
* Inability to pass the orogastric decompression tube into the stomach
* Coagulopathy (INR \> 2 or platelet count \< 50,000 per cubic millimeter)
* Inability to provide informed consent
* Eastern Cooperative Oncology Group (ECOG) performance status \> 2
* Risk of thrombosis is determined to be too high to hold anti-platelets (other than aspirin) or anticoagulants prior to the procedure.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07222657
Study Brief:
Protocol Section:
NCT07222657